A.A. Quézada Bautista , J.C. Lara Bejarano , J.A. García García , J.L. Gaxiola Sosa , A. López Azcarraga , M.Y. Bautista Hernández
{"title":"结外MALT淋巴瘤的放疗结果。病例报告及文献复习","authors":"A.A. Quézada Bautista , J.C. Lara Bejarano , J.A. García García , J.L. Gaxiola Sosa , A. López Azcarraga , M.Y. Bautista Hernández","doi":"10.1016/j.hgmx.2016.04.003","DOIUrl":null,"url":null,"abstract":"<div><p>Mucosa-associated lymphoid tissue (MALT) represents 8% of non-Hodgkin lymphomas (NHL), with 2% affecting the conjunctiva. The case is presented of a 19-year-old patient diagnosed with conjunctival MALT lymphoma of the right eye, treated with external radiotherapy (ERT), and showing a complete, 100% response. At 18 months, no signs of relapse.</p><p>The treatment of choice for MALT type extranodal lymphoma is ERT. It has shown excellent results in controlling the disease, overall survival, progression-free survival and relapse-free survival. The relapse rate is 6–27% and the transformation to a higher grade lymphoma between 18% and 23%, consequently patients must have adequate follow-up. If the above is confirmed, reirradiation, chemotherapy and/or molecular target-directed therapy should be considered.</p></div>","PeriodicalId":31559,"journal":{"name":"Revista Medica del Hospital General de Mexico","volume":"79 4","pages":"Pages 223-229"},"PeriodicalIF":0.0000,"publicationDate":"2016-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.hgmx.2016.04.003","citationCount":"0","resultStr":"{\"title\":\"Results of radiotherapy in extranodal MALT lymphoma. A case report and literature review\",\"authors\":\"A.A. Quézada Bautista , J.C. Lara Bejarano , J.A. García García , J.L. Gaxiola Sosa , A. López Azcarraga , M.Y. Bautista Hernández\",\"doi\":\"10.1016/j.hgmx.2016.04.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Mucosa-associated lymphoid tissue (MALT) represents 8% of non-Hodgkin lymphomas (NHL), with 2% affecting the conjunctiva. The case is presented of a 19-year-old patient diagnosed with conjunctival MALT lymphoma of the right eye, treated with external radiotherapy (ERT), and showing a complete, 100% response. At 18 months, no signs of relapse.</p><p>The treatment of choice for MALT type extranodal lymphoma is ERT. It has shown excellent results in controlling the disease, overall survival, progression-free survival and relapse-free survival. The relapse rate is 6–27% and the transformation to a higher grade lymphoma between 18% and 23%, consequently patients must have adequate follow-up. If the above is confirmed, reirradiation, chemotherapy and/or molecular target-directed therapy should be considered.</p></div>\",\"PeriodicalId\":31559,\"journal\":{\"name\":\"Revista Medica del Hospital General de Mexico\",\"volume\":\"79 4\",\"pages\":\"Pages 223-229\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.hgmx.2016.04.003\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista Medica del Hospital General de Mexico\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0185106316300130\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Medica del Hospital General de Mexico","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0185106316300130","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Results of radiotherapy in extranodal MALT lymphoma. A case report and literature review
Mucosa-associated lymphoid tissue (MALT) represents 8% of non-Hodgkin lymphomas (NHL), with 2% affecting the conjunctiva. The case is presented of a 19-year-old patient diagnosed with conjunctival MALT lymphoma of the right eye, treated with external radiotherapy (ERT), and showing a complete, 100% response. At 18 months, no signs of relapse.
The treatment of choice for MALT type extranodal lymphoma is ERT. It has shown excellent results in controlling the disease, overall survival, progression-free survival and relapse-free survival. The relapse rate is 6–27% and the transformation to a higher grade lymphoma between 18% and 23%, consequently patients must have adequate follow-up. If the above is confirmed, reirradiation, chemotherapy and/or molecular target-directed therapy should be considered.
期刊介绍：
The Medical Journal of the Hospital General de Mexico is the official organ of the Medical Society of the Hospital General de Mexico. The journal accepts articles in Spanish or in English on the field of hospital medicine. The journal publishes original articles, clinical cases, reviews articles, history notes, issues on medical education, short communications and editorials at the invitation of the Society. All articles are double blind peer reviewed by at least 2 reviewers and finally classified as accepted or rejected by the Editorial Board.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
